Iovance Biotherapeutics Inc. buy The Goldman Sachs Group, Inc.
Start price
20.02.24
/
50%
€11.80
Target price
20.02.25
€17.55
Performance (%)
-13.73%
Price
10.05.24
€10.18
Summary
This prediction is currently active. The prediction for Iovance Biotherapeutics Inc. disappoints with a performance of -13.73%. This prediction currently runs until 20.02.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Iovance Biotherapeutics Inc. | -19.684% | -19.684% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $13.00 to $19.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€14.52
29.02.24
29.02.24
€19.38
28.02.25
28.02.25
-29.89%
10.05.24
10.05.24
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.05
20.11.23
20.11.23
€10.98
20.11.24
20.11.24
101.58%
10.05.24
10.05.24